Elon Musk’s brain-implant company Neuralink announced that it will begin high-volume production of its brain-computer interface devices in 2026 and transition to a fully automated surgical procedure, according to a post Musk shared on the social media platform X. Neuralink did not immediately respond to requests for comment.
The implant is designed to assist people with neurological conditions, including spinal cord injuries. The first patients have used the device to play video games, browse the internet, post on social media, and control a cursor on a laptop using only their thoughts.
Neuralink began human trials of its brain implant in 2024 after addressing safety concerns raised by the U.S. Food and Drug Administration, which had initially rejected its application in 2022. By September 2025, the company reported that 12 individuals with severe paralysis worldwide had received implants and were using them to operate digital and physical tools through thought. In addition, Neuralink secured $650 million in funding during a June investment round, supporting the company’s expansion and development of its next-generation brain-computer interface technology.
